April 29, 2025 07:22 AM EDTUpdated 08:43 AM
China
Pharma
Manufacturing

As­traZeneca, No­var­tis ex­e­cute ‘US for US’ strat­e­gy as phar­ma tar­iffs near

Anna Brown

News Reporter

With the in­dus­try on ten­ter­hooks on what the phar­ma-spe­cif­ic tar­iffs may look like, As­traZeneca and No­var­tis said Tues­day that their lo­cal pro­duc­tion ca­pac­i­ty will be …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

FDA de­lays PDU­FA date for small biotech, rais­ing ques­tions about im­pact of agency cuts

FDA ap­proves Abeona’s skin dis­ease cell ther­a­py

Pfiz­er launch­es a new wave of cost cuts, ex­pects $7.7B in to­tal sav­ings through 2027

With a new CEO, oligonu­cleotide biotech Crey­on forges Eli Lil­ly part­ner­ship

Oc­ta­gon Ther­a­peu­tics shuts down af­ter 'un­re­solved bi­ol­o­gy ques­tion­s'

sponsored

Rev­o­lu­tion­iz­ing obe­si­ty treat­ment: Could mi­to­chon­dria hold the key to un­lock­ing fat-spe­cif­ic weight loss?

A service from the Financial Times